Nu Skin Enterprises to Announce Third Quarter 2026 Financial Results
Nu Skin: The Turnaround Is Behind Before It's Started
Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
Nu Skin Enterprises (NUS) Price Target Increased by 70.27% to 13.03
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
Nu Skin Enterprises Q2 Earnings Call Highlights
Nu Skin Enterprises, Inc. 2026 Q2 - Results - Earnings Call Presentation
Nu Skin Enterprises Reports Second Quarter Results
Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Enterprises Sees FY2026 GAAP EPS $(4.90)-$(4.73)
Nu Skin Enterprises Sees Q3 GAAP EPS $0.00-$0.09
Nu Skin Enterprises Sees FY2026 Adj EPS $0.70-$0.90 vs $1.00 Est; Lowers FY2026 Sales Guidance from $1.350B-$1.500B to $1.280B-$1.350B vs $1.425B Est
Nu Skin Enterprises Sees Q3 Adj EPS $0.10-$0.20 vs $0.32 Est; Sees Sales $310.000M-$340.000M vs $375.500M Est
Nu Skin Enterprises Q2 Adj. EPS $0.20, Inline, Sales $320.112M Miss $345.200M Estimate
Nu Skin Enterprises, Inc. Q2 2026 Earnings Call Summary
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
Nu Skin Enterprises Stockholders Approve Amended And Restated 2024 Omnibus Incentive Plan; Amended Plan Increases Share Authorization By 2.85M Shares; Plan Termination Date Extended To May 28, 2036
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.